Table 1.
Characteristics of patients and RHC procedures.
Total | Age < 75 years | Age ≥ 75 years | P | |
---|---|---|---|---|
(n = 1060) | (n = 832) | (n = 228) | ||
Age (years) | 66 ± 14.2 | 61 ± 12.7 | 79 ± 3.5 | |
Female gender (n (%)) | 580 (54.7) | 458 (55.0) | 122 (53.5) | 0.679 |
BMI (kg/m2) | 25.8 ± 6.34 | 25.6 ± 6.5 | 26.3 ± 5.7 | 0.199 |
RHC (n (%)) | <0.001 | |||
Baseline | 369 (34.8) | 272 (32.7) | 97 (42.5) | |
Follow-up | 691 (65.2) | 560 (67.3) | 131 (57.5) | |
Vascular access site (n (%)) | 0.553 | |||
Humeral vein | 513 (49.4) | 397 (48.5) | 116 (52.7) | |
Femoral vein | 522 (50.2) | 418 (51.1) | 104 (47.3) | |
Internal jugular vein | 3 (0.3) | 3 (0.4) | – | |
Dose length product (Gy/cm2) | 6 ± 16.7 | 5 ± 15.8 | 6 ± 19.7 | 0.090 |
Hemodynamic diagnosis | 0.475 | |||
RHC (n) | 369 | 272 | 97 | |
Normal (n (%)) | 92 (25.0) | 71 (26.1) | 21 (21.6) | |
Pre-capillary PH (n (%)) | 224 (60.8) | 165 (60.7) | 59 (60.8) | |
Post-capillary PH (n (%)) | 33 (8.9) | 23 (8.4) | 10 (10.4) | |
Combined PH (n (%)) | 18 (4.9) | 12 (4.4) | 6 (6.2) | |
Hyperdynamic state (n (%)) | 2 (0.5) | 1 (0.4) | 1 (1.0) | |
PH etiological group (n) | 242 | 177 | 65 | 0.03 |
Group 1 (n (%)) | 110 (45.5) | 86 (48.6) | 24 (36.9) | |
Group 3 (n (%)) | 75 (31.0) | 52 (29.4) | 23 (35.4) | |
Group 4 (n (%)) | 38 (15.7) | 22 (12.4) | 16 (24.6) | |
Group 5 (n (%)) | 19 (7.8) | 17 (9.6) | 2 (3.1) | |
Adverse events (n (%)) | 9 (0.9) | 6 (0.7) | 3 (1.3) | 0.513 |
Local vascular injury | 8 (0.8) | 5 (0.6) | 3 (1.3) | |
Cardiac complications | 1 (0.1) | 1 (0.1) | – |
BMI, body mass index; RHC, right heart catheterization; PH, pulmonary hypertension.